Surgical Science (UK) Insiders

Surgical Science Management Team Effectiveness

The company has return on total asset (ROA) of 0.0177 % which means that it generated a profit of $0.0177 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0287 %, meaning that it generated $0.0287 on every $100 dollars invested by stockholders. Surgical Science's management efficiency ratios could be used to measure how well Surgical Science manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Surgical Science's Net Tangible Assets are comparatively stable compared to the past year. Total Current Assets is likely to gain to about 997.8 M in 2025, whereas Other Assets are likely to drop slightly above 19.3 M in 2025. Net Income Applicable To Common Shares is likely to gain to about 227 M in 2025

Surgical Science Workforce Comparison

The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.

Surgical Science Sweden Benchmark Summation

Surgical Science Notable Stakeholders

The success or failure of an entity such as Surgical Science Sweden often depends on how effective the management is. Surgical Science management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Surgical management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Surgical management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Surgical Science's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Surgical Science Sweden. Check Surgical Science's Beneish M Score to see the likelihood of Surgical Science's management manipulating its earnings.

When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.